Jack Jennings

Associate Professor, Department of Radiology, Washington University’s Mallinckrodt Institute of Radiology, Missouri, USA

Dr. Jack Jennings is an Associate Professor in the Department of Radiology at Washington University’s Mallinckrodt Institute of Radiology and serves as the director of Musculoskeletal and Spine Intervention.

Dr. Jennings has co-authored over 40 peer-reviewed journal articles, review articles, and book chapters. He is an active manuscript reviewer for such journals as Radiology, American Journal of Radiology, Skeletal Radiology, and Cardiovascular and Interventional Radiology.  He has done over 50 invited lectureships with the majority focusing on musculoskeletal and spine tumor ablation.  He created the multi-disciplinary metastatic spine disease working group in Dallas 2014 composed of  recognized experts in the fields of medical, radiation, and surgical oncology and interventional radiology which led to the published algorithms and straightforward recommendations for the treatment of metastatic spine disease, including percutaneous tumor ablation.

Dr. Jennings has presented at several national radiology and musculoskeletal society meetings, including invited talks at the American Society of Spine Radiology (2012-2017), Interventional Oncology Sans Frontieres Milan (2013), Radiology Society of North America (2014), World Conference of Interventional Oncology (2014, 2017), Society of Interventional Radiology (2015,2016), and European Conference of Interventional Oncology (2017). He is an active member in these societies including serving on Executive, Program, Clinical Practice, Nominating and Informatics Committees (ASSR). Dr. Jennings main research interest lies in musculoskeletal and spine tumor ablation and he is currently involved in multiple funded prospective studies and is the local and national Principal Investigator on a spine tumor ablation and a bone cryoablation study.   In addition he has numerous scientific abstracts and presentations at national and international society meetings. Locally, he is involved in many multi-disciplinary tumor boards and hospital committees.